Topics

Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology

09:32 EST 14 Nov 2019 | Xconomy

[Updated, 12:15 p.m. See below.] Inside of a cell, some proteins and RNA are concentrated in liquid droplets that assemble in formation during a variety of cellular functions. Dewpoint Therapeutics is making headway understanding the role these droplets play in disease, and that work now has Bayer as a research partner. Bayer and Dewpoint on […]

Original Article: Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology

NEXT ARTICLE

More From BioPortfolio on "Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...